Anadys and LG Life Sciences are jointly developing ANA380 on a global basis.

ANA380is an oral prodrug ANA380 ANA317 a nucleotide analog for the treatment of chronic HBV infection. Anadys and LG Life Sciences are jointly developing ANA380 on a global basis. In April 2004, Anadys acquired an exclusive license from LG Life Sciences for the commercialization of ANA380 in North America, Japan and the rest of the world except China, India and countries in Southeast Asia.

We are delighted by ANA380 promising clinical results and we believe that these highlight highlight the potential of ANA380 for the next generation therapy for HBV patients, said In-Chull Kim, President and Chief Executive Officer of. LG Life Sciences We are excited to move forward to plan with Anadys the next stages of clinical development. .Hotel Ways and Means Committee’with friendly permission of to can all Kaiser Daily HealthPolicyMonitor show Report looking for browsing the archives and you can subscribe for mail infeed on Kaiser Daily Health policy coverage released emphasis to kaisernetwork.org, a free service from of The Henry J. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Scientist and pharmaceutical companies are narrow examining the role of melanine – concentrating hormone neurons in controlling the food intake and energy. Past studies have shown to MCH power of lab animals eat longer, longer sleep and have less energy. In contrast to that other neurons of the hypothalamus the thyrotropin-releasing hormone as neurotransmitters, and these neurons are reduce food intake and body by weight and increase physical activity.

Other entries from category "clinical":

Random entries